FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
Email: info@eosmedchem.com; eosmedchem@gmail.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
APX-3330, 136164-66-4, APX-3330 Intermediate 136165-80-5, stock 350.8g, white powder, assay by HPLC 98.4%, HNMR, LCMS we supply.
APX-3330, 136164-66-4, APX-3330 Intermediate 150626-27-0, stock 268.2g, white powder, assay by HPLC 98.3%, HNMR, LCMS we supply.
APX-3330, 136164-66-4, APX-3330 Intermediate 136165-70-3, stock 793.7g, white powder, assay by HPLC 99.1%, HNMR, LCMS we supply.
APX-3330, 136164-66-4, APX-3330 Intermediate 136165-71-4, stock 450.9g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply.
APX-3330, 136164-66-4, APX-3330 Intermediate 136163-71-8, stock 231.2g, white powder, assay by HPLC 98.9%, HNMR, LCMS we supply.
APX-3330, 136164-66-4, APX-3330 Intermediate 136164-66-4, stock 918.9g, white powder, assay by HPLC 100%, HNMR, LCMS we supply.
